# Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

> **NCT00890903** · — · COMPLETED · sponsor: **Pierre Fabre Pharma GmbH** · enrollment: 62 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma
- Metastatic Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00890903
- **Lead sponsor:** Pierre Fabre Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2012-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890903, "Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00890903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*